We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+44.63%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$1.1B
AUM Growth
–
Cap. Flow
+$968M
Cap. Flow %
87.8%
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$337M
2
NRIX icon
Nurix Therapeutics
NRIX
+$178M
3
RVMD icon
Revolution Medicines
RVMD
+$142M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$137M
5
RAPT
RAPT Therapeutics
RAPT
+$106M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$467M 42.31%
+15,396,116
New +$337M
NRIX icon
2
Nurix Therapeutics
NRIX
$2.81B
$177M 16.06%
+5,383,333
New +$178M
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.44B
$161M 14.64%
+4,768,181
New +$137M
RVMD icon
4
Revolution Medicines
RVMD
$43.7B
$142M 12.86%
+3,580,252
New +$142M
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$76.7M 6.96%
+485,710
New +$106M
CNST
6
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$75.6M 6.86%
+2,626,631
New +$66.1M
GRTS
7
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$3.43M 0.31%
+869,493
New +$2.63M

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Column Group, which disclosed 7 positions worth $1.1B. Its ten largest holdings account for 100% of the portfolio.

Its largest position is NGM Biopharmaceuticals, Inc. Common Stock: 15,396,116 shares worth $467M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Column Group's largest Q4 2020 buy was NGM Biopharmaceuticals, Inc. Common Stock: 15,396,116 shares worth $467M.
  • Column Group's ten largest holdings make up 100% of its $1.1B portfolio in Q4 2020.
  • Column Group disclosed 7 positions in Q4 2020, its first 13F filing on record.

Based on Column Group's 13F filing for Q4 2020, filed 16 Feb 2021.